Dr. José Ángel Rubiño | Health Professions | Best Researcher Award

Dr. José Ángel Rubiño | Health Professions | Best Researcher Award

Professor, University of the Balearic Islands, Spain

Dr. José Ángel Rubiño-Díaz is a distinguished Spanish researcher and academic specializing in chronobiology, neuropsychology, and nursing. With a career spanning over two decades, he has made remarkable contributions to biological rhythms, sleep neurophysiology, and clinical neuroscience. As a dedicated nurse, psychologist, and neuroscientist, he seamlessly integrates his expertise across disciplines. He is currently affiliated with the Universitat de les Illes Balears (UIB) and Hospital Universitario Son Espases (HUSE), where he actively engages in teaching, research, and clinical practice. His work has been recognized with multiple research awards, and he continues to contribute significantly to scientific literature and academic mentorship.

Publication Profile

ORCID

🎓 Academic Background

Dr. Rubiño-Díaz earned his Nursing degree from the University of Almería (1999) and later pursued a Psychology degree at the University of Granada (2003). His academic journey continued with a Master’s in Neuroscience from the Universitat de les Illes Balears (2011), where he later completed his Ph.D. in Neuroscience (2019) with Cum Laude distinction. He also holds a Diploma in Advanced Studies in Psychobiology from UNED (2013). His extensive postgraduate training includes research methodologies and bibliographic studies, further enhancing his contributions to neuroscience and clinical psychology.

💼 Professional Experience

Dr. Rubiño-Díaz has built a multifaceted career encompassing clinical, academic, and research roles. He has been a faculty member at UIB since 2011, teaching in nursing and psychology programs, and has supervised multiple master’s theses and doctoral research. In addition to his academic role, he serves as a researcher at HUSE, where he focuses on sleep neurophysiology, biological rhythms, and neuropsychology. His clinical expertise extends to his role as a nurse in emergency care and as a clinical psychologist specializing in neuropsychology. He is also the coordinator of the Neuropsychology Working Group at the Official College of Psychologists of the Balearic Islands (GT-NPS-COPIB), actively engaging in scientific dissemination and clinical training.

🏆 Awards and Honors

Dr. Rubiño-Díaz’s groundbreaking research has been recognized with several prestigious awards. He received research excellence awards from HUSE in 2017 and 2020 for his contributions to nursing and neuroscience. His project on sleep and rest in emergency services was awarded at the 1st International Congress on Humanization in Emergency Medicine. His continuous academic and research excellence has earned him significant recognition in the fields of neuropsychology, nursing, and biological rhythms.

🔬 Research Focus

Dr. Rubiño-Díaz’s research revolves around chronobiology, neuropsychology, and biological rhythms, with a particular focus on sleep neurophysiology. He has conducted pioneering studies on the impact of sleep on cognitive function and mental health, exploring interventions like light therapy for improving mood and sleep quality in the elderly. His research spans nursing, psychobiology, and neuroscience, making significant contributions to the understanding of non-REM and REM sleep, circadian rhythms, and their effects on health and well-being. As an investigator in multiple research groups, he collaborates on projects advancing clinical applications of sleep science.

🔍 Conclusion

Dr. José Ángel Rubiño-Díaz stands as a leading figure in the intersection of nursing, psychology, and neuroscience. His commitment to scientific research, clinical practice, and academic mentorship reflects his passion for advancing medical knowledge. With an extensive publication record, multiple research collaborations, and dedication to healthcare innovation, he continues to impact neuropsychology, sleep research, and emergency nursing. His work is shaping the future of biological rhythm studies and patient-centered healthcare.

📚 Publication Top Notes

The Disputable Costs of Sleeping (2025) – Biology
DOI: 10.3390/biology14040352
A multidisciplinary study analyzing the economic and biological costs of sleep patterns in mammals.

Actitudes y motivaciones en la investigación enfermera en un hospital de nivel III (2024) – Index de Enfermería Digital
DOI: 10.58807/indexenferm20246855
Investigates the research attitudes and motivations among nursing professionals in a tertiary hospital.

Mammalian NREM and REM sleep: Why, when and how (2023) – Neuroscience & Biobehavioral Reviews
DOI: 10.1016/j.neubiorev.2023.105041
Explores the evolutionary and functional aspects of NREM and REM sleep in mammals.

The Birth of the Mammalian Sleep (2022) – Biology
DOI: 10.3390/biology11050734
Examines the origins and development of sleep mechanisms in mammals.

Efecto positivo de la terapia de luz brillante sobre el estado de ánimo y la calidad del sueño en las personas mayores institucionalizadas (2021) – Revista Española de Geriatría y Gerontología
 Demonstrates the benefits of bright light therapy on mood and sleep quality in elderly populations.

Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Associate Professor, New York College of Podiatric Medicine, United States

Dr. Paramita Basu is a distinguished scientist and educator specializing in infectious diseases, pharmaceutical sciences, and microbiology. Currently, she serves as an Associate Professor and Director of Infectious Diseases at the New York College of Podiatric Medicine and an Associate Professor of Pharmaceutical & Biomedical Sciences at Touro College of Pharmacy, New York. With a Ph.D. in Biological Sciences from St. John’s University, she has made significant contributions to research on biofilms, antibiotic resistance, and innovative learning methodologies. As a dedicated academic leader, she also chairs the Curriculum Committee at Touro College of Pharmacy, shaping the future of pharmaceutical education.

Publication Profile

🎓 Education

Dr. Basu earned her Ph.D. in Biological Sciences from St. John’s University, Queens, New York (2003-2008). Her research during this period focused on microbial resistance and biofilm control mechanisms, laying the foundation for her impactful work in microbiology and pharmaceutical sciences.

💼 Experience

With over a decade of experience in academia, Dr. Basu has held key positions in medical and pharmaceutical education. Since 2009, she has been an Associate Professor at Touro College of Pharmacy, where she teaches pharmaceutical and biomedical sciences. In 2022, she joined the New York College of Podiatric Medicine as the Director of Infectious Diseases, focusing on pre-clinical sciences and microbiology. Her expertise extends to curriculum development, interdisciplinary education, and research on antibiotic resistance in clinical settings.

🏆 Awards and Honors

Dr. Basu has received multiple recognitions for her outstanding research and academic contributions. She has been acknowledged for her pioneering work in antimicrobial resistance, biofilm studies, and the integration of audiovisual learning in medical education. Her research has been published in top-tier scientific journals, reflecting her impact on global microbiology and pharmaceutical sciences.

🔬 Research Focus

Dr. Basu’s research interests revolve around biofilm formation, antibiotic resistance mechanisms, and innovative drug therapies. Her work has significantly contributed to understanding Pseudomonas aeruginosa biofilms, Vibrio gazogenes interactions, and novel antibiotic treatments. Additionally, she explores the role of multimedia learning tools in medical education, aiming to improve student engagement and knowledge retention in pharmaceutical sciences.

🔎 Conclusion

Dr. Paramita Basu is a renowned microbiologist, educator, and researcher with a passion for antimicrobial resistance and innovative learning in pharmaceutical sciences. Her groundbreaking work in infectious disease research and medical education has solidified her position as a leader in the field. With a commitment to scientific advancement and student success, she continues to make a significant impact in pharmaceutical and biomedical sciences. 🚀

📚 Publications

Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review Acta Microbiologica Hellenica (2025) [🔗DOI: 10.3390/amh70010009]

Integration of an Audiovisual Learning Resource in a Podiatric Medical Infectious Disease Course: Multiple Cohort Pilot Study – JMIR Medical Education (2025) [🔗DOI: 10.2196/55206]

Study of the impact of introducing a multimedia learning tool in podiatric medical courses – Journal of Foot and Ankle Research (2024) [🔗DOI: 10.1002/jfa2.12018]

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance – Journal of Experimental Biology and Agricultural Sciences (2024) [🔗DOI: 10.18006/2024.12(2).274.283]

Vibrio gazogenes-dependent disruption of aflatoxin biosynthesis in Aspergillus flavus – Frontiers in Microbiology (2023) [🔗DOI: 10.3389/fmicb.2023.1208961]

The Effect of Antibiotic Treatment and Gene Expression of Mex B Efflux Transporters on the Resistance in Pseudomonas Aeruginosa Biofilms Applied Microbiology (2023) [🔗DOI: 10.3390/applmicrobiol3030049]

Surveillance of SARS-CoV-2 RNA in open-water sewage canals – Access Microbiology (2022) [🔗DOI: 10.1099/acmi.0.000318]

Antimicrobial Resistance in Pseudomonas aeruginosa Biofilms – Journal of Pure and Applied Microbiology (2021) [🔗DOI: 10.22207/JPAM.15.4.79]

Prof. Jie Lu | Health Sciences | Best Scholar Award

Prof. Jie Lu | Health Sciences | Best Scholar Award

Vice advisor, The Affiliated Hospital of Qingdao University, China

Dr. Jie Lu is a distinguished medical researcher and Associate Professor at The Affiliated Hospital of Qingdao University. With a strong background in internal medicine, endocrinology, and metabolism, Dr. Lu has made significant contributions to the field of hyperuricemia and gout research. His expertise in molecular and clinical studies has led to groundbreaking findings, including the development of a spontaneous hyperuricemia mouse model and critical insights into the relationship between hyperuricemia and metabolic disorders. His research has been widely recognized, earning him prestigious awards and global collaborations.

Publication Profile

🎓 Education

Dr. Jie Lu completed his MD and PhD in Internal Medicine from Qingdao University (2015-2018), following an MS in Endocrine and Metabolism (2012-2015) from the same institution. His academic journey began with a Bachelor’s in Medicine from Shandong Second Medical University (2007-2012), laying a strong foundation for his career in medical research.

👨‍🔬 Experience

Dr. Lu has been serving as an Associate Professor at The Affiliated Hospital of Qingdao University since 2022. Prior to this, he worked as a Research Fellow at the same institution (2018-2022), where he played a pivotal role in advancing hyperuricemia research. His international training experience spans institutions such as the University of Otago, Henry Ford Immunology Program in the USA, and the Chinese Academy of Sciences, enriching his expertise in bioinformatics, immunology, and molecular biology.

🏆 Awards and Honors

Dr. Lu’s excellence in medical research has been recognized through numerous prestigious awards. In 2022, he received the 13th Qingdao Youth Science and Technology Award. His contributions to scientific progress earned him the First Award of Shandong Province Science and Technology Progress in 2020. Throughout his academic career, he has been honored with multiple scholarships, including the National Graduate Scholarship (2017), Excellent Student Scholarship (2016-2017), and Freshman Scholarship (2015). His outstanding performance as a researcher and student has been acknowledged with multiple “Excellent Graduate” awards from Shandong Province and Qingdao University.

🔬 Research Focus

Dr. Lu’s research is dedicated to understanding the clinical and molecular mechanisms of hyperuricemia and gout. His pioneering work in constructing a spontaneous hyperuricemia mouse model has provided invaluable insights into disease progression and treatment strategies. His studies explore the relationship between hyperuricemia and renal function, diabetes, and arterial sclerosis, with high-impact publications in leading journals such as Nature Reviews Rheumatology, Kidney International, and Diabetes. He has also been instrumental in identifying the impact of COVID-19 vaccination on gout attacks, proposing colchicine as a preventive treatment.

🏁 Conclusion

Dr. Jie Lu is a leading researcher in hyperuricemia and gout, with a remarkable academic and research career. His extensive publications, international collaborations, and pioneering research have significantly contributed to the medical field. Recognized for his scientific achievements, Dr. Lu continues to make impactful discoveries that shape the future of metabolic disease treatment.

📚 Publications

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccinationAnnals of the Rheumatic Diseases, 2022 🔗

Mouse models for human hyperuricaemia: a critical reviewNature Reviews Rheumatology, 2019 🔗

Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disordersKidney International, 2018 🔗

Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic β-cell death in uricase-deficient male miceDiabetes, 2020 🔗

Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse modelThe FEBS Journal, 2019 🔗

Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretionArthritis Rheumatol, 2022 🔗

Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout FlaresArthritis Rheumatol, 2023 🔗

Profiling of Serum Oxylipins Identifies Distinct Spectrums and Potential Biomarkers in Young People with Very Early Onset GoutRheumatology (Oxford), 2023 🔗

Effects of fenofibrate therapy on renal function in primary gout patientsRheumatology (Oxford), 2021 🔗

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational studyJoint Bone Spine, 2020 🔗